腫瘍におけるコンパニオン診断検査の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Companion Diagnostic Tests in Oncology Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：MRC2012B0226 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、腫瘍におけるコンパニオン診断検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。腫瘍におけるコンパニオン診断検査の種類別市場規模（タンパク質検出、DNA検出）、用途別市場規模（製薬・バイオテクノロジー企業、医療機器企業、研究機関）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott、Illumina、QIAGEN、Roche、BioMerieux、Genomic Health、Thermo Fisher、Agendia、Agilent、Siemens Healthcare、 ・地域別グローバル市場分析 2015年-2020年 ・腫瘍におけるコンパニオン診断検査の北米市場（アメリカ、カナダ、メキシコ） ・腫瘍におけるコンパニオン診断検査のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・腫瘍におけるコンパニオン診断検査のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・腫瘍におけるコンパニオン診断検査の南米市場（ブラジル、アルゼンチン） ・腫瘍におけるコンパニオン診断検査の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：タンパク質検出、DNA検出 ・用途別分析：製薬・バイオテクノロジー企業、医療機器企業、研究機関 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Companion Diagnostic Tests in Oncology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.1% in the forecast period of 2020 to 2025 and will expected to reach USD 5315.9 million by 2025, from USD 3749.9 million in 2019.

The Companion Diagnostic Tests in Oncology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Companion Diagnostic Tests in Oncology market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Companion Diagnostic Tests in Oncology market has been segmented into:
Protein Detection
DNA Detection

By Application, Companion Diagnostic Tests in Oncology has been segmented into:
Pharmaceutical & Biotechnology Companies
Medical Device Companies
Research Institutes

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Companion Diagnostic Tests in Oncology market presented in the report. This section sheds light on the sales growth of different regional and country-level Companion Diagnostic Tests in Oncology markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Companion Diagnostic Tests in Oncology market.

The report offers in-depth assessment of the growth and other aspects of the Companion Diagnostic Tests in Oncology market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Companion Diagnostic Tests in Oncology Market Share Analysis
Companion Diagnostic Tests in Oncology competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Companion Diagnostic Tests in Oncology sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Companion Diagnostic Tests in Oncology sales, revenue and market share for each player covered in this report.

The major players covered in Companion Diagnostic Tests in Oncology are:
Abbott
Illumina
QIAGEN
Roche
BioMerieux
Genomic Health
Thermo Fisher
Agendia
Agilent
Siemens Healthcare

レポート目次

---

Table of Contents

1 Companion Diagnostic Tests in Oncology Market Overview
1.1 Product Overview and Scope of Companion Diagnostic Tests in Oncology
1.2 Classification of Companion Diagnostic Tests in Oncology by Type
1.2.1 Global Companion Diagnostic Tests in Oncology Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type in 2019
1.2.3 Protein Detection
1.2.4 DNA Detection
1.3 Global Companion Diagnostic Tests in Oncology Market by Application
1.3.1 Overview: Global Companion Diagnostic Tests in Oncology Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Medical Device Companies
1.3.4 Research Institutes
1.4 Global Companion Diagnostic Tests in Oncology Market by Regions
1.4.1 Global Companion Diagnostic Tests in Oncology Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Companion Diagnostic Tests in Oncology (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Companion Diagnostic Tests in Oncology Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Companion Diagnostic Tests in Oncology Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Companion Diagnostic Tests in Oncology Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Companion Diagnostic Tests in Oncology Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Companion Diagnostic Tests in Oncology Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.2 Illumina
2.2.1 Illumina Details
2.2.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Illumina SWOT Analysis
2.2.4 Illumina Product and Services
2.2.5 Illumina Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.3 QIAGEN
2.3.1 QIAGEN Details
2.3.2 QIAGEN Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 QIAGEN SWOT Analysis
2.3.4 QIAGEN Product and Services
2.3.5 QIAGEN Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.5 BioMerieux
2.5.1 BioMerieux Details
2.5.2 BioMerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 BioMerieux SWOT Analysis
2.5.4 BioMerieux Product and Services
2.5.5 BioMerieux Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.6 Genomic Health
2.6.1 Genomic Health Details
2.6.2 Genomic Health Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Genomic Health SWOT Analysis
2.6.4 Genomic Health Product and Services
2.6.5 Genomic Health Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.7 Thermo Fisher
2.7.1 Thermo Fisher Details
2.7.2 Thermo Fisher Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Thermo Fisher SWOT Analysis
2.7.4 Thermo Fisher Product and Services
2.7.5 Thermo Fisher Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.8 Agendia
2.8.1 Agendia Details
2.8.2 Agendia Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Agendia SWOT Analysis
2.8.4 Agendia Product and Services
2.8.5 Agendia Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.9 Agilent
2.9.1 Agilent Details
2.9.2 Agilent Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Agilent SWOT Analysis
2.9.4 Agilent Product and Services
2.9.5 Agilent Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.10 Siemens Healthcare
2.10.1 Siemens Healthcare Details
2.10.2 Siemens Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Siemens Healthcare SWOT Analysis
2.10.4 Siemens Healthcare Product and Services
2.10.5 Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Companion Diagnostic Tests in Oncology Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Companion Diagnostic Tests in Oncology Players Market Share
3.2.2 Top 10 Companion Diagnostic Tests in Oncology Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Companion Diagnostic Tests in Oncology Revenue and Market Share by Regions
4.2 North America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
4.3 Europe Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
4.5 South America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
5 North America Companion Diagnostic Tests in Oncology Revenue by Countries
5.1 North America Companion Diagnostic Tests in Oncology Revenue by Countries (2015-2020)
5.2 USA Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
5.3 Canada Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
5.4 Mexico Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
6 Europe Companion Diagnostic Tests in Oncology Revenue by Countries
6.1 Europe Companion Diagnostic Tests in Oncology Revenue by Countries (2015-2020)
6.2 Germany Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
6.3 UK Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
6.4 France Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
6.5 Russia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
6.6 Italy Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue by Countries
7.1 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue by Countries (2015-2020)
7.2 China Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
7.3 Japan Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
7.4 Korea Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
7.5 India Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
8 South America Companion Diagnostic Tests in Oncology Revenue by Countries
8.1 South America Companion Diagnostic Tests in Oncology Revenue by Countries (2015-2020)
8.2 Brazil Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
8.3 Argentina Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Companion Diagnostic Tests in Oncology by Countries
9.1 Middle East & Africa Companion Diagnostic Tests in Oncology Revenue by Countries (2015-2020)
9.2 Saudi Arabia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
9.3 UAE Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
9.4 Egypt Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
9.5 South Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Companion Diagnostic Tests in Oncology Revenue and Market Share by Type (2015-2020)
10.2 Global Companion Diagnostic Tests in Oncology Market Forecast by Type (2019-2024)
10.3 Protein Detection Revenue Growth Rate (2015-2025)
10.4 DNA Detection Revenue Growth Rate (2015-2025)
11 Global Companion Diagnostic Tests in Oncology Market Segment by Application
11.1 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2015-2020)
11.2 Companion Diagnostic Tests in Oncology Market Forecast by Application (2019-2024)
11.3 Pharmaceutical & Biotechnology Companies Revenue Growth (2015-2020)
11.4 Medical Device Companies Revenue Growth (2015-2020)
11.5 Research Institutes Revenue Growth (2015-2020)
12 Global Companion Diagnostic Tests in Oncology Market Size Forecast (2021-2025)
12.1 Global Companion Diagnostic Tests in Oncology Market Size Forecast (2021-2025)
12.2 Global Companion Diagnostic Tests in Oncology Market Forecast by Regions (2021-2025)
12.3 North America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2021-2025)
12.4 Europe Companion Diagnostic Tests in Oncology Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Forecast (2021-2025)
12.6 South America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Companion Diagnostic Tests in Oncology Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Companion Diagnostic Tests in Oncology Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Companion Diagnostic Tests in Oncology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Companion Diagnostic Tests in Oncology Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Companion Diagnostic Tests in Oncology Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Corporate Information, Location and Competitors
Table 6. Abbott Companion Diagnostic Tests in Oncology Major Business
Table 7. Abbott Companion Diagnostic Tests in Oncology Total Revenue (USD Million) (2017-2018)
Table 8. Abbott SWOT Analysis
Table 9. Abbott Companion Diagnostic Tests in Oncology Product and Solutions
Table 10. Abbott Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Illumina Corporate Information, Location and Competitors
Table 12. Illumina Companion Diagnostic Tests in Oncology Major Business
Table 13. Illumina Companion Diagnostic Tests in Oncology Total Revenue (USD Million) (2018-2019)
Table 14. Illumina SWOT Analysis
Table 15. Illumina Companion Diagnostic Tests in Oncology Product and Solutions
Table 16. Illumina Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. QIAGEN Corporate Information, Location and Competitors
Table 18. QIAGEN Companion Diagnostic Tests in Oncology Major Business
Table 19. QIAGEN Companion Diagnostic Tests in Oncology Total Revenue (USD Million) (2017-2018)
Table 20. QIAGEN SWOT Analysis
Table 21. QIAGEN Companion Diagnostic Tests in Oncology Product and Solutions
Table 22. QIAGEN Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Roche Corporate Information, Location and Competitors
Table 24. Roche Companion Diagnostic Tests in Oncology Major Business
Table 25. Roche Companion Diagnostic Tests in Oncology Total Revenue (USD Million) (2017-2018)
Table 26. Roche SWOT Analysis
Table 27. Roche Companion Diagnostic Tests in Oncology Product and Solutions
Table 28. Roche Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. BioMerieux Corporate Information, Location and Competitors
Table 30. BioMerieux Companion Diagnostic Tests in Oncology Major Business
Table 31. BioMerieux Companion Diagnostic Tests in Oncology Total Revenue (USD Million) (2017-2018)
Table 32. BioMerieux SWOT Analysis
Table 33. BioMerieux Companion Diagnostic Tests in Oncology Product and Solutions
Table 34. BioMerieux Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Genomic Health Corporate Information, Location and Competitors
Table 36. Genomic Health Companion Diagnostic Tests in Oncology Major Business
Table 37. Genomic Health Companion Diagnostic Tests in Oncology Total Revenue (USD Million) (2017-2018)
Table 38. Genomic Health SWOT Analysis
Table 39. Genomic Health Companion Diagnostic Tests in Oncology Product and Solutions
Table 40. Genomic Health Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Thermo Fisher Corporate Information, Location and Competitors
Table 42. Thermo Fisher Companion Diagnostic Tests in Oncology Major Business
Table 43. Thermo Fisher Companion Diagnostic Tests in Oncology Total Revenue (USD Million) (2017-2018)
Table 44. Thermo Fisher SWOT Analysis
Table 45. Thermo Fisher Companion Diagnostic Tests in Oncology Product and Solutions
Table 46. Thermo Fisher Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Agendia Corporate Information, Location and Competitors
Table 48. Agendia Companion Diagnostic Tests in Oncology Major Business
Table 49. Agendia Companion Diagnostic Tests in Oncology Total Revenue (USD Million) (2017-2018)
Table 50. Agendia SWOT Analysis
Table 51. Agendia Companion Diagnostic Tests in Oncology Product and Solutions
Table 52. Agendia Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Agilent Corporate Information, Location and Competitors
Table 54. Agilent Companion Diagnostic Tests in Oncology Major Business
Table 55. Agilent Companion Diagnostic Tests in Oncology Total Revenue (USD Million) (2017-2018)
Table 56. Agilent SWOT Analysis
Table 57. Agilent Companion Diagnostic Tests in Oncology Product and Solutions
Table 58. Agilent Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Siemens Healthcare Corporate Information, Location and Competitors
Table 60. Siemens Healthcare Companion Diagnostic Tests in Oncology Major Business
Table 61. Siemens Healthcare Companion Diagnostic Tests in Oncology Total Revenue (USD Million) (2017-2018)
Table 62. Siemens Healthcare SWOT Analysis
Table 63. Siemens Healthcare Companion Diagnostic Tests in Oncology Product and Solutions
Table 64. Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Players (2015-2020)
Table 66. Global Companion Diagnostic Tests in Oncology Revenue Share by Players (2015-2020)
Table 67. Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions (2015-2020)
Table 69. North America Companion Diagnostic Tests in Oncology Revenue by Countries (2015-2020)
Table 70. North America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2015-2020)
Table 71. Europe Companion Diagnostic Tests in Oncology Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Companion Diagnostic Tests in Oncology Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Companion Diagnostic Tests in Oncology Revenue by Countries (2015-2020)
Table 74. South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Companion Diagnostic Tests in Oncology Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2015-2020)
Table 77. Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Type (2015-2020)
Table 78. Global Companion Diagnostic Tests in Oncology Revenue Share by Type (2015-2020)
Table 79. Global Companion Diagnostic Tests in Oncology Revenue Forecast by Type (2021-2025)
Table 80. Global Companion Diagnostic Tests in Oncology Revenue by Application (2015-2020)
Table 81. Global Companion Diagnostic Tests in Oncology Revenue Share by Application (2015-2020)
Table 82. Global Companion Diagnostic Tests in Oncology Revenue Forecast by Application (2021-2025)
Table 83. Global Companion Diagnostic Tests in Oncology Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Companion Diagnostic Tests in Oncology Picture
Figure 2. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type in 2019
Figure 3. Protein Detection Picture
Figure 4. DNA Detection Picture
Figure 5. Companion Diagnostic Tests in Oncology Revenue Market Share by Application in 2019
Figure 6. Pharmaceutical & Biotechnology Companies Picture
Figure 7. Medical Device Companies Picture
Figure 8. Research Institutes Picture
Figure 9. Global Companion Diagnostic Tests in Oncology Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Companion Diagnostic Tests in Oncology Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Companion Diagnostic Tests in Oncology Revenue Market Share in 2019
Figure 18. Global Top 10 Players Companion Diagnostic Tests in Oncology Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions (2015-2020)
Figure 22. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions in 2018
Figure 23. North America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 24. Europe Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 26. South America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 28. North America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2015-2020)
Figure 29. North America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2019
Figure 30. USA Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 31. Canada Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 33. Europe Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2019
Figure 35. Germany Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 36. UK Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 37. France Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 38. Russia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 39. Italy Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2019
Figure 42. China Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 43. Japan Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 44. Korea Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 45. India Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 47. South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2015-2020)
Figure 48. South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2019
Figure 49. Brazil Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 54. UAE Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2015-2020)
Figure 57. Global Companion Diagnostic Tests in Oncology Revenue Share by Type (2015-2020)
Figure 58. Global Companion Diagnostic Tests in Oncology Revenue Share by Type in 2019
Figure 59. Global Companion Diagnostic Tests in Oncology Market Share Forecast by Type (2021-2025)
Figure 60. Global Protein Detection Revenue Growth Rate (2015-2020)
Figure 61. Global DNA Detection Revenue Growth Rate (2015-2020)
Figure 62. Global Companion Diagnostic Tests in Oncology Revenue Share by Application (2015-2020)
Figure 63. Global Companion Diagnostic Tests in Oncology Revenue Share by Application in 2019
Figure 64. Global Companion Diagnostic Tests in Oncology Market Share Forecast by Application (2021-2025)
Figure 65. Global Pharmaceutical & Biotechnology Companies Revenue Growth Rate (2015-2020)
Figure 66. Global Medical Device Companies Revenue Growth Rate (2015-2020)
Figure 67. Global Research Institutes Revenue Growth Rate (2015-2020)
Figure 68. Global Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Companion Diagnostic Tests in Oncology Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Companion Diagnostic Tests in Oncology Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2021-2025)
Figure 72. Europe Companion Diagnostic Tests in Oncology Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Forecast (2021-2025)
Figure 74. South America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---